CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Résumé de cet Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xia, Z.
Right arrow Articles by Flameng, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xia, Z.
Right arrow Articles by Flameng, W.
Canadian Journal of Anesthesia 50:481-488 (2003)
© Canadian Anesthesiologists' Society, 2003

Cardiothoracic Anesthesia, Respiration and Airway

Remote preconditioning lessens the deterioration of pulmonary function after repeated coronary artery occlusion and reperfusion in sheep

Un préconditionnement éloigné diminue la détérioration de la fonction pulmonaire après l’occlusion et la reperfusion répétées de l’artère coronaire

Zhengyuan Xia, MD, Paul Herijgers, MD PhD, Takahiro Nishida, MD, Shigeyuki Ozaki, MD PhD, Patrick Wouters, MD PhD and Willem Flameng, MD PhD

From the Cardiovascular Research Unit, Center for Experimental Surgery Anaesthesiology (C.E.H.A.), K.U. Leuven, Leuven, Belgium.

Address correspondence to: Prof. Dr. Paul Herijgers, C.E.H.A., K.U. Leuven, Provisorium 1, Minderbroedersstraat 17, B-3000, Leuven, Belgium. Phone: +32-16-337298; Fax: +32-16-337855; E-mail: paul.herijgers{at}med.kuleuven.ac.be


    Abstract
 TOP
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Purpose: We investigated whether remote organ preconditioning (RPC) can preserve pulmonary function following repeated myocardial ischemia/reperfusion in a model mimicking multi-vessel off-pump coronary artery bypass (OPCAB) revascularization.

Methods: Nine sheep (Group-RPC) underwent RPC by three episodes of five-minute occlusion and five-minute reperfusion of the iliac artery. Five sheep (Group-C) were time-matched controls. Afterwards, ten-minute occlusion and reperfusion of the left anterior descending, the first diagonal and the left circumflex coronary arteries were performed consecutively. Hemodynamic and respiratory parameters and arterial blood gases were measured until 120 min after the final coronary reperfusion. Anesthesia was maintained with halothane in oxygen and nitrous oxide. Animals were ventilated with a tidal volume of 15–20 mL•kg-1 in a non-rebreathing system, and a respiratory rate 14–16 min, with 5-cm H2O positive end expiratory pressure after thoracotomy.

Results: Repeated coronary occlusion and reperfusion was associated in this experimental model with an increase in pulmonary vascular resistance (PVR) and pulmonary arterial pressure (PAP) and a decrease in PaO2 and PaO2/FIO2 in Group-C. After 120 min reperfusion, PaO2 and PaO2/FIO2 in Group-RPC were higher (192 ± 69 mmHg and 241 ± 78 vs 115 ± 54 mmHg and 129 ± 64, P < 0.05), while PVR and PAP were lower than in Group-C. At 120 min of reperfusion, PaO2 and PaO2/FIO2 were inversely correlated with PVR (P < 0.01).

Conclusions: RPC by transient occlusion of the iliac artery improves lung gas exchange after repeated coronary artery occlusion and reperfusion mimicking OPCAB surgery, and preserves low PVR in sheep.


    Introduction
 TOP
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
FOLLOWING cardiac surgery, pulmonary dysfunction rate ranges from < 2% (adult respiratory distress syndrome) to 64% (postoperative atelectasis),1 and is one of the major contributors to postoperative morbidity and mortality. Off-pump coronary artery bypass (OPCAB) surgery may have the potential advantage of reducing postoperative pulmonary dysfunction compared with conventional coronary artery bypass grafting (CABG) using extra-corporeal circulation. Manipulation of the heart during exposure of the obtuse marginal or the right CABG during OPCAB might, however, cause valvular regurgitation and jeopardize hemodynamics and pulmonary function. Also, patients with severe left ventricular dysfunction (ejection fraction < 30%) will occasionally experience a rise in pulmonary arterial pressure (PAP) during OPCAB2 due to further ischemic deterioration of the ventricle. The rise in pulmonary artery pressure is followed by a drop in systolic pressure and a significant decrease in myocardial contractility,2 compromising the safe completion of the procedures without cardiopulmonary bypass (CPB). Respiratory insufficiency accounts for one tenth (4/39) of the causes of early postoperative death in 2,052 patients receiving OPCAB surgery as reported by Tasdemir et al.3 A transesophageal echocardiographic study showed that a five-minute coronary occlusion was associated with significantly elevated left ventricular wall motion score and concomitant significantly increased pulmonary artery pressure in patients undergoing OPCAB surgery.4 Other laboratory findings have shown that coronary artery occlusion caused pulmonary damage that was worsened by coronary reperfusion.5 All this suggests that although OPCAB surgery allows avoiding the deleterious pulmonary effects of CPB, there still might be pulmonary dysfunction caused by the OPCAB procedure.6,7 Therefore, techniques to reduce pulmonary dysfunction may enhance the safety of coronary artery bypass surgery even when extra-corporeal circulation is avoided.

It has been reported that brief ischemia of remote organs (remote preconditioning, RPC), such as mesentery8 or gastrocnemius muscle,9 can reduce myocardial infarct size following prolonged ischemia and improve myocardial function. This RPC is much more attractive than the classical cardiac ischemic preconditioning since it avoids aortic cross clamping with its inherent risk of cerebral emboli. Moreover, in the case of beating heart OPCAB surgery, aortic cross clamping is, of course, impossible. It was shown recently that cardiac ischemic preconditioning protects pulmonary function in heart valve surgery.10 The effect of RPC on pulmonary function has not yet been fully explored. We postulated that RPC could improve lung gas exchange following myocardial ischemia/reperfusion. We tested this hypothesis using a clinically relevant animal model of OPCAB surgery in which RPC was achieved by three episodes of brief iliac artery occlusion and reperfusion, and myocardial ischemia and reperfusion was achieved by consecutive occlusion/reperfusion of three main coronary arteries.


    Methods
 TOP
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Animal preparation
All animals received humane care in compliance with the European Convention on Animal Care. The animal Ethics Committee of the Katholieke Universiteit Leuven approved the study. Fourteen adult sheep weighing between 53–65 kg were used in this study. Nine sheep were pretreated by RPC, and, five control sheep were used. The sheep were fasted for 48 hr, but access to water was allowed until 20–24 hr before anesthesia.

Anesthesia and surgical procedure
The sheep were given im ketamine 15–20 mg•kg-1. Anesthesia was induced with halothane (1–4 vol%) in oxygen and maintained after endotracheal intubation with halothane (1.5–2.0 vol%) in a mixture of oxygen and nitrous oxide. The animals were ventilated mechanically (Engström model 200, Engström, Sweden) at a respiratory rate of 14–16•min-1, an in-to expiratory cycle ratio of 1:2, and the tidal volume (15–20 mL•kg-1) was individually adjusted to maintain arterial carbon dioxide tension (PaCO2) between 35 to 45 mmHg. The tidal volume and respiratory rate for individual animals was not further adjusted during the experiment after baseline normal PaCO2 was achieved. Sigh breaths were given to treat increasing airway pressures. Angiocatheters (18 G and 20 G) were inserted respectively into a peripheral vein and a left ear artery for iv infusion and for arterial blood pressure monitoring and arterial blood sampling. A catheter was introduced into the right atrium through the jugular vein for continuous monitoring of central venous pressure. The electrocardiogram was monitored continuously. Fentanyl (0.1 mg, Janssen, Beerse, Belgium) was given before surgery and was further administered in boluses during thoracotomy. Physiological saline was given intravenously at a constant rate of 6 mL•kg-1•min-1 throughout the procedure. Heparin (400 IU•kg-1 iv) was administered before any vascular occlusion.

After a left thoracotomy was performed in the third intercostal space and the fourth rib was removed, a positive end-expiratory pressure of 5 cm H2O was established. A 20-mm ultrasonic flow probe connected to a flow meter (Transonic System, Ithaca, NY, USA) was placed around the pulmonary artery for cardiac output (CO) measurement. Three fluid-filled pressure catheters were placed to measure left atrial, pulmonary artery, and aortic pressures. Suture snares were put respectively around the left anterior descending coronary artery distal to the first diagonal branch, the first diagonal branch itself and the left circumflex coronary artery. The left external iliac artery was exposed for RPC. All the hemodynamic variables were continuously recorded on a heat-writing recorder (Nihon-Kohden, Tokyo, Japan) after signal conditioning with a carrier-amplifier (Triton Technology, San Diego, CA, USA). All signals were digitized on-line at 200 Hz with an analogue to digital converter equipped in the Conduct-PC hardware (CardioDynamics, Leiden, the Netherlands) and recorded on a computer. Blood gas variables were obtained from an automated blood gas analyzer (ABL3, Radiometer, Copenhagen, Denmark). The pulmonary vascular resistance (PVR) was calculated as: PVR = 80*(PAP-LAP)/CO from PAP, left atrial pressure (LAP) and CO.

Experimental protocol
Fourteen sheep were randomly assigned by using sealed envelopes to a control group (Group-C, n = 5) and a RPC group (Group-RPC, n = 9). Blood gases, respiratory and basic hemodynamic variables were recorded after induction of anesthesia. During instrumentation, basic hemodynamic variables did not change, and baseline data were recorded ten minutes after completion of the surgical instrumentation. RPC was subsequently achieved by three episodes of five-minute occlusion followed by five-minute reperfusion of the iliac artery, and data after preconditioning were recorded ten minutes after the final reperfusion of the iliac artery, or time-matched in Group-C which did not undergo iliac artery occlusion and reperfusion.

Subsequently, animals in both groups were subjected to repeated coronary occlusion and reperfusion. Firstly, the left anterior descending coronary artery was occluded for ten minutes. Ten minutes after left anterior descending coronary reperfusion, the first diagonal branch was occluded for ten minutes followed by reperfusion, ten minutes afterwards, the circumflex was occluded for ten minutes and then reperfused. Arterial blood samples were taken, and hemodynamic and respiratory variables recorded every 30 min after circumflex reperfusion until 120 min. Successful coronary occlusion was checked, by observing the immediate colour change of the tissues perfused by the corresponding arteries. Reperfusion was checked by the return of the bright red colour of the tissues. After the completion of the experiment, suture snares were checked to see if they completely circled coronary arteries, to ensure that occlusion of the corresponding coronary arteries was complete in each animal.

Statistical analysis
The significance of differences within the same group was determined by repeated measures ANOVA, with Dunnett’s multiple comparison test and Tukey’s multiple comparison test as appropriate. Statistical significance between the two groups was determined using unpaired Student’s t test with Welch’s correction. All data are presented as mean ± standard deviation (SD) and P < 0.05 was considered significant. Power calculations comparing the two groups were performed for the observed values obtained after 120 min of reperfusion (the final measurement) for the major outcomes concerning pulmonary function: this gives for PAP ß = 0.83, PVR ß = 0.91, PAP-LAP ß = 0.92, PaO2 ß = 0.77, PaO2/FIO2 ß = 0.85. The power calculations were performed using the online power calculators from the UCLA Department of Statistics (http://calculators.stat.ucla.edu/powercalc/).


    Results
 TOP
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Animals in Group-RPC and Group-C did not differ significantly in body weight (58.3 ± 5.9 kg vs 60.0 ± 3.4 kg), anesthetic doses used, fractional inspired oxygen (FIO2) and peak airway pressure throughout the procedure (Table IGo). As shown in Table IIGo, hemodynamic variables were comparable in both groups at baseline. RPC immediately decreased the PVR. Mean PAP and PVR in Group-C increased gradually during reperfusion and after 120 min of reperfusion were higher than the corresponding baseline values. RPC prevented this increase in mean PAP and PVR. An increase of the transpulmonary pressure gradient, calculated as the pressure difference between the mean PAP and LAP, was observed in Group-C after reperfusion. This transpulmonary pressure gradient was higher in the control group than that in Group-RPC after 90 and 120 min of reperfusion. Repeated coronary occlusion and reperfusion was associated with a decrease in systemic arterial pressure and CO in both Group-C and Group-RPC. After 120 min reperfusion, the mean systemic arterial pressure and CO was lower in Group C than in Group RPC. Heart rate, LAP and central venous pressure did not change significantly over time in either group.


View this table:
[in this window]
[in a new window]
 
TABLE I Anesthetic gas and ventilatory variables
 

View this table:
[in this window]
[in a new window]
 
TABLE II Hemodynamic variables
 
PaO2 and PaO2/FIO2 in Group-C decreased progressively after reperfusion and were lower than the baseline values after 120 min of reperfusion (Table IIIGo). However, no significant changes of PaO2 and PaO2/FIO2 were observed in Group-RPC throughout the procedure. After 120 min of reperfusion, PaO2 and PaO2/FIO2 in Group-C were lower than that in Group-RPC (P < 0.05). Concomitantly, PaCO2 in Group-C increased after 90 min reperfusion and was higher than that in Group-RPC (Table IIIGo). In Group-RPC, PaCO2 and pH values remained within the normal range after reperfusion.


View this table:
[in this window]
[in a new window]
 
TABLE III Arterial blood gases
 
Figure 1Go depicts the negative correlation between PVR and PaO2 as well as PaO2/FIO2 after 120 min reperfusion (P < 0.01). As shown in Figure 2Go, changes of PVR 30 min after reperfusion were correlated with impaired PaO2 and PaO2/FIO2 after 120 min of reperfusion.



View larger version (25K):
[in this window]
[in a new window]
 
FIGURE 1 Correlation between pulmonary vascular resistance (PVR) and PaO2 and PaO2/FIO2 after 120 min reperfusion. After 120 min reperfusion, PVR negatively correlated with PaO2 (r = -0.6660, P = 0.009, top) and with PaO2/FIO2 (r = -0.7493, P = 0.002, bottom).

 


View larger version (24K):
[in this window]
[in a new window]
 
FIGURE 2 Pulmonary vascular resistance (PVR) after 30 min reperfusion predicted changes of PaO2 and PaO2/FIO2 after 120 min reperfusion. PVR after 30 min reperfusion negatively correlated with PaO2 (r = -0.5712, P = 0.03, top) and with PaO2/FIO2 (r = -0.6743, P = 0.008, bottom) after 120 min reperfusion.

 

    Discussion
 TOP
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
This experiment suggests that brief remote ischemic preconditioning prevents the increase in pulmonary artery pressures following consecutive multiple coronary arteries occlusion and reperfusion, a situation that mimics clinical OPCAB surgery. Our main findings are: (a) this experimental protocol with consecutive coronary occlusion-reperfusion increases PVR and jeopardizes lung gas exchange, which is evidenced by the reduced PaO2 and PaO2/FIO2 after reperfusion in the control group; (b) RPC reduces PVR and improves lung gas exchange after repeated coronary artery occlusion and reperfusion, and reduces PVR.

Postoperative pulmonary dysfunction, a potentially lethal syndrome, has been reported to occur after OPCAB surgery,2,4 vascular surgery11 and after CPB.12,13 It is associated with a significant decrease in PaO2 and PaO2/FIO2. OPCAB surgery implies one or more coronary arteries to undergo occlusion and reperfusion. During reperfusion, specific myocardial enzymes (presumably leaked from damaged or necrotic tissue) and inflammatory cytokines14 are being washed out and reach the lungs,15 which might lead to lung injury. A series of acute experimental studies5,16–18 has demonstrated that coronary artery occlusion and reperfusion resulted in pulmonary edema, evidenced by an increase in extra-vascular lung water. Increased pulmonary microvascular permeability is suggested as one of the possible mechanisms. Although the mediators of the rise in pulmonary permeability have not been clearly identified, increasing evidence suggests that IL-6, IL-814 and prostaglandins19 are among the potential contributors. Infusing indomethacin19 reduced extra-vascular lung water after coronary artery occlusion in dogs. In a sheep model, Stamler et al.20 and Friedman et al.21 showed that myocardial ischemia and reperfusion was associated with an increase in PVR, which was accompanied by an increase in plasma thromboxane. Inhibition of thromboxane synthesis eliminated the lung injury seen in this model.21 Extra-vascular lung water was not measured in our model. Given the increase of PAP and PVR in Group-C, combined with a continuous decrease of PaO2 and PaO2/FIO2 as well as an increase in PaCO2, pulmonary edema may be one of the major contributors to the deterioration of pulmonary function in our model.

Recently, Fehrenbach et al.19 reported that the extent of lung epithelial injury increased with PVR using an isolated heart-lung ischemia-reperfusion model, suggesting PVR is a reliable indirect indicator of lung injury. The fact that PVR increased after coronary artery occlusion-reperfusion in Group-C, and that PaO2 and PaO2/FIO2 after 120 min reperfusion were negatively correlated with this early rise in PVR further supports this finding (Figure 2Go). This suggests that changes in PVR could serve as a sensitive predictor for pulmonary function deterioration after coronary occlusion/reperfusion in this model. Acute postoperative pulmonary hypertension and elevated PVR may cause morbidity and mortality in patients undergoing cardiac surgery involving CPB.22 Recently, Li et al.10 reported that two cycles of three minutes of aortic cross clamping and two minutes of reperfusion (cardiac ischemic preconditioning) before cardioplegic arrest improves lung function in patients undergoing valve replacement operations. In their observations, two cycles of brief cardiac ischemic preconditioning were associated with a reduced PVR index and mean pulmonary artery pressure, which was accompanied by improved cardiac index as well as enhanced PaO2 after reperfusion. Also, histological findings confirmed a reduced alveolar injury in the cardiac ischemic preconditioned group.10 However, the method of global ischemic cardiac preconditioning is not applicable when OPCAB surgery is performed, since no aortic cross-clamping is possible during beating heart surgery. Furthermore, this method carries the risk of neurological damage by embolism of atheromatous material in the aorta during the cross-clamping. Therefore preconditioning by a short occlusion of a peripheral region or organ as performed in our experiments might clinically be far more relevant.

We report that sheep, submitted to a clinically relevant model mimicking OPCAB surgery, show an increase in PVR and jeopardized lung gas exchange. RPC induced by short ischemia of a non-vital organ completely prevented the increase of PVR and preserved lung gas exchange following coronary artery occlusion and reperfusion in our model. The underlying mechanism of the observations described in this experiment and in that of Li et al.10 needs to be further elucidated. It is not clear whether the same underlying mechanism is responsible for both observations. It is tempting, although speculative, to attribute a role to the KATP channel, since: 1) activation of this channel causes pulmonary vascular vasodilatation;23,24 and 2) the end effector of myocardial protection by ischemic preconditioning is at least in part the KATP channel.25,26 Further studies are warranted to unravel the underlying mechanism.

One may argue that the improvement in pulmonary function seen in Group-RPC might be attributable to the improvement in cardiac function as evidenced by increased CO and systemic arterial pressure in our experiment. We cannot completely exclude this possibility but think that this is not likely the major mechanism for the improvement in pulmonary function after repeated coronary occlusion and reperfusion in our model. Significant differences in CO and systemic arterial pressure between the groups were not observed until after 120 min reperfusion, while PaO2/FIO2 was already significantly lower and PaCO2 significantly higher in Group-C than in Group-RPC after 90 min of reperfusion (Tables IIGo and IIIGo). Furthermore, there was no correlation between CO or systemic arterial pressure and pulmonary function described by PaO2/FIO2 and PaO2.

A weakness of our study is the fact that no control group was included without RPC and without coronary occlusions. Addition of this group might have clearly demonstrated the effect of the consecutive episodes of myocardial ischemia and reperfusion in itself. We had chosen to start with a model that mimics clinical OPCAB surgery, and then to try to reduce the pulmonary functional deterioration in this model by RPC.

In conclusion, the present study shows that in this sheep model, brief periods of ischemia followed by reperfusion in a remote peripheral non-vital organ can prevent pulmonary dysfunction following myocardial ischemia and reperfusion. This study may have clinical implications in OPCAB surgery. It might be of particular importance to those patients who have preexisting high PVR and pulmonary hypertension.


    Footnotes
 
This study was supported by a Research Grant from the Fund for Scientific Research – Flanders (Belgium; F.W.O.-Vlaanderen, KAN2001-1.5.057.01).

Revision received February 12, 2003. Accepted for publication October 22, 2002.


    References
 TOP
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
1 Hachenberg T, Tenling A, Nystrom SO, Tyden H, Hedenstierna G. Ventilation-perfusion inequality in patients undergoing cardiac surgery. Anesthesiology 1994; 80: 509–19.[Medline]

2 Dagenais F, Cartier R. Pulmonary hypertension during beating heart coronary surgery: intermittent inferior vena cava snaring. Ann Thorac Surg 1999; 68: 1094–5.[Abstract/Free Full Text]

3 Tasdemir O, Vural KM, Karagoz H, Bayazit K. Coronary artery bypass grafting on the beating heart without the use of extracorporeal circulation: review of 2052 cases. J Thorac Cardiovasc Surg 1998; 116: 68–73.[Abstract/Free Full Text]

4 Malkowski MJ, Kramer CM, Parvizi ST, et al. Transient ischemia does not limit subsequent ischemic regional dysfunction in humans: a transesophageal echocardiographic study during minimally invasive coronary artery bypass surgery. J Am Coll Cardiol 1998; 31: 1035–9.[Abstract/Free Full Text]

5 Slutsky RA, Mattrey RF. Pulmonary edema formation after myocardial infarction and coronary reperfusion: intravascular and extravascular pulmonary fluid volumes. IV. Circ Shock 1984; 13: 183–91.[Medline]

6 Güler M, Kirali K, Toker ME, et al. Different CABG methods in patients with chronic obstructive pulmonary disease. Ann Thorac Surg 2001; 71: 152–7.[Abstract/Free Full Text]

7 Meharwal ZS, Mishra YK, Kohli V, Bapna R, Singh S, Trehan N. Off-pump multivessel coronary artery surgery in high-risk patients. Ann Thorac Surg 2002; 74: S1353–7.[Abstract/Free Full Text]

8 Gho BC, Schoemaker RG, van den Doel MA, Duncker DJ, Verdouw PD. Myocardial protection by brief ischemia in noncardiac tissue. Circulation 1996; 94: 2193–200.[Abstract/Free Full Text]

9 Birnbaum Y, Hale SL, Kloner RA. Ischemia preconditioning at a distance. Reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in the rabbit. Circulation 1997; 96: 1641–6.[Abstract/Free Full Text]

10 Li G, Chen S, Lu E, Luo W. Cardiac ischemic preconditioning improves lung preservation in valve replacement operations. Ann Thorac Surg 2001; 71: 631–5.[Abstract/Free Full Text]

11 Groeneveld AB, Raijmakers PG, Rauwerda JA, Hack CE. The inflammatory response to vascular surgery-associated ischaemia and reperfusion in man: effect on postoperative pulmonary function. Eur J Vasc Endovasc Surg 1997; 14: 351–9.[Medline]

12 Latson TW, Kickler TS, Baumgartner WA. Pulmonary hypertension and noncardiogenic pulmonary edema following cardiopulmonary bypass asociated with an antigranulocyte antibody. Anesthesiology 1986; 64: 106–11.[Medline]

13 Boldt J, von Bormann B, Kling D, Scheld HH, Hempelmann G. The influence of extracorporeal circulation on extravascular lung water in coronary surgery patients. Thorac Cardiovasc Surg 1986; 34: 110–5.

14 Neumann FJ, Ott I, Gawaz M, et al. Cardiac release of cytokines and inflammatory response in acute myocardial infarction. Circulation 1995; 92: 748–55.[Abstract/Free Full Text]

15 Liebold A, Keyl C, Birnbaum DE. The heart produces but the lungs consume proinflammatory cytokins following cardiopulmonary bypass. Eur J Cardiothorac Surg 1999; 15: 340–5.[Abstract/Free Full Text]

16 Slutsky RA, Peck WW, Higgins CB. Pulmonary edema formation with myocardial infarction and left atrial hypertension: intravascular and extravascular pulmonary fluid volumes. Circulation 1983; 68: 164–9.[Abstract/Free Full Text]

17 Richeson JF, Paulshock C, Yu PN. Non-hydrostatic pulmonary edema after coronary artery ligation in dogs. Protective effect of indomethacin. Circ Res 1982; 50: 301–9.[Abstract/Free Full Text]

18 Collins JC, Harris TR, McKeen CR, Brigham KL. Increased lung lymph transport without heart failure after coronary ligation in sheep. J Appl Physiol 1979; 47: 792–7.[Abstract/Free Full Text]

19 Fehrenbach H, Schepelmann D, Albes JM, et al. Pulmonary ischemia/reperfusion injury: a quantitative study of structure and function in isolated heart-lungs of the rat. Anat Rec 1999; 255: 84–9.[Medline]

20 Stamler A, Wang H, Weintraub RM, Hariawala MD, Fink MP, Johnson RG. Low-dose dopexamine’s effect on lung and gut function after CPB in a sheep model. J Surg Res 1998; 74: 165–72.[Medline]

21 Friedman M, Wang SY, Sellke FW, Franklin A, Weintraub RM, Johnson RG. Pulmonary injury after total or partial cardiopulmonary bypass with thromboxane synthesis inhibition. Ann Thorac Surg 1995; 59: 598–603.[Abstract/Free Full Text]

22 Hopkins RA, Bull C, Haworth SG, de Leval MR, Stark J. Pulmonary hypertensive crises following surgery for congenital heart defects in young children. Eur J Cardiothorac Surg 1991; 5: 628–34.[Abstract]

23 Hood JS, McMahon TJ, Kadowitz PJ. Pulmonary vasodilator responses to RP52891 are mediated by activation of a glibenclamide-sensitive K+ATP channel. Eur J Pharmacol 1991; 202: 121–4.[Medline]

24 Minkes RK, Kvamme P, Higuera TR, Nossaman BD, Kadowitz PJ. Analysis of pulmonary and systemic vascular responses to cromakalim, an activator of K+ATP channels. Am J Physiol 1991; 260: H957–66.

25 Grover GJ, Garlid KD. ATP-sensitive potassium channels: a review of their cardioprotective pharmacology. J Mol Cell Cardiol 2000; 32: 677–95.[Medline]

26 Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 1992; 70: 223–33.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
Br J AnaesthHome page
S. R. Walsh, T. Tang, U. Sadat, D. P. Dutka, and M. E. Gaunt
Cardioprotection by remote ischaemic preconditioning
Br. J. Anaesth., November 1, 2007; 99(5): 611 - 616.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. Ramzy, V. Rao, and R. D. Weisel
Clinical applicability of preconditioning and postconditioning: The cardiothoracic surgeons's view
Cardiovasc Res, May 1, 2006; 70(2): 174 - 180.
[Full Text] [PDF]


Home page
ICVTSHome page
Z. Xia, R. Xia, H.-T. Lan, T. Luo, Q.-Z. Tang, Z.-Y. Xia, and X.-Y. Liu
Systemic ischemic preconditioning plus hemodilution enhanced early functional recovery of reperfused heart in the rabbits
Interactive CardioVascular and Thoracic Surgery, September 1, 2004; 3(3): 528 - 532.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Résumé de cet Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xia, Z.
Right arrow Articles by Flameng, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xia, Z.
Right arrow Articles by Flameng, W.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS